Qingdao Etsong Bioengineering is a medical device company committed to developing and marketing innovative new generation wound care products. We have developed a unique, all natural, and revolutionary hemostatic product, which is represented by HYCELLU
Medafor, Inc. develops and markets an innovative breakthrough in hemostatic technology and absorbable hemostats called Microporous Polysaccharide Hemospheres (MPH®).
PerClot technology modifies plant starch into ultra-hydrophilic, adhesive forming hemostatic polymers. PerClot particles are biocompatible, absorbable polysaccharides containing no animal or human components.
PerClot technology modifies plant starch into ultra-hydrophilic, adhesive forming hemostatic polymers. PerClot particles are biocompatible, absorbable polysaccharides containing no animal or human components.
Qingdao Etsong Bioengineering is a medical device company committed to developing and marketing innovative new generation wound care products. We have developed a unique, all natural, and revolutionary hemostatic product, which is represented by HYCELLU